Chinese herbs may be greatly beneficial in the health terrain. Being previously assumed as helpful in treating eczema, the herbs are now beneficial for reducing side effects. Experts from the Yale University declare a combination of Chinese herbs to apparently decrease gastrointestinal side effects of chemotherapy and elevate the effects of cancer treatment in mice. These Chinese herbs are claimed to have been used from more than 1,800 years.
Four herbs were apparently combined together for forming the formula in the experiment. This formula known as PHY906 is ascertained to be based on the herbal recipe called Huang Qin Tang. This herbal recipe may be normally employed for treating nausea, vomiting and diarrhea. Experts aimed to analyze the benefits of it in declining gastrointestinal effects of a common chemotherapy drug without interfering its ability to destroy cancerous cells.
Yung-Chi ‘Tommy’ Cheng, Henry Bronson professor of pharmacology, co-director of the Yale Cancer Center’s Developmental Therapeutics program and senior author of the paper shared, “Chemotherapy causes great distress for millions of patients, but PHY906 has multiple biologically active compounds which can act on multiple sources of discomfort.”
Chemotherapy is known to generate various toxic side effects that are seemingly treated with the help of different drugs. Scientists enlighten that a drawback of these medications is the inability to display positive results all the time. It was noted that mice subjected to chemotherapy and provided with PHY906 had lost less weight and experienced more anti-tumor activity than mice not given the formula.
Experts concluded that the herbal formula decreased toxicity of the chemotherapy by multiple mechanisms namely the inhibiting inflammation. The formula was also affirmed to boost the creation of new intestinal cells. It was mentioned that this formula cannot be beneficial if provided with the present day drugs that target only one mechanism. A combination of chemotherapy and herbs is assumed to be a potential approach for the treatment of cancer.
The research was published on August 18 in the journal Science Translational Medicine.